| Continuing operations revenue | 4,707.9a | 4,282.8a |
| Cost of sales | -3,407.8a | -3,128.3a |
| Gross profit | 1,300.1a | 1,154.5a |
| Research and development expenses | -123.2a | -149.8a |
| Selling, general and administrative expenses | -565.4a | -535a |
| Other (gains) and losses | -13.3a | 27.9a |
| Share of after-tax profit of equity accounted investees | -88.3a | -72.2a |
| Restructuring, integration and acquisition costs | -56.5a | -131.4a |
| Impairment of goodwill | | -568a |
| Gain on remeasurement of previously held equity interest | -72.6a | |
| Operating income (loss) | 729.2a | -185.4a |
| Finance expense - net | -215.5a | -205a |
| Earnings (loss) before income taxes | 513.7a | -390.4a |
| Income tax expense (recovery) | -98.7a | -72.8a |
| Net income (loss) from continuing operations | 415a | -317.6a |
| Net income from discontinued operations | | 21.3a |
| Net income (loss) | 415a | -296.3a |
| Attributable to: | — | — |
| Equity holders of the Company | 405.3a | -304a |
| Non-controlling interests | 9.7a | 7.7a |